Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancer
- Resource Type
- Article
- Source
- In
Bioorganic Chemistry October 2022 127 - Subject
- Language
- ISSN
- 0045-2068